XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm Study

You may be eligible if

• The patient must be at least 18 years of age at the time of signing the informed consent.
• The patient or his/her legally-authorized representative signs the European Commission (EC)-approved Informed Consent Form (ICF).
• Only XIENCE PRIME stent(s) is (are) implanted during the index procedure.